Sei Investments Co. lessened its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 12.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 233,378 shares of the medical research company’s stock after selling 32,337 shares during the period. Sei Investments Co. owned about 0.06% of Thermo Fisher Scientific worth $40,718,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of TMO. Proficio Capital Partners LLC raised its holdings in shares of Thermo Fisher Scientific by 71.5% in the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after acquiring an additional 253 shares during the last quarter. Cribstone Capital Management LLC raised its holdings in shares of Thermo Fisher Scientific by 8.7% in the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after acquiring an additional 50 shares during the last quarter. Sharkey Howes & Javer raised its holdings in shares of Thermo Fisher Scientific by 1.0% in the 1st quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after acquiring an additional 7 shares during the last quarter. CWM LLC raised its holdings in shares of Thermo Fisher Scientific by 17.0% in the 2nd quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after acquiring an additional 103 shares during the last quarter. Finally, Grove Bank & Trust raised its holdings in shares of Thermo Fisher Scientific by 19.9% in the 2nd quarter. Grove Bank & Trust now owns 860 shares of the medical research company’s stock worth $150,000 after acquiring an additional 143 shares during the last quarter. Institutional investors own 83.52% of the company’s stock.

A number of equities research analysts recently weighed in on TMO shares. Jefferies Group LLC restated a “hold” rating and issued a $175.00 target price on shares of Thermo Fisher Scientific in a report on Wednesday, May 17th. Cantor Fitzgerald assumed coverage on shares of Thermo Fisher Scientific in a research note on Thursday, May 18th. They issued an “overweight” rating and a $194.00 price objective for the company. Deutsche Bank AG set a $200.00 price objective on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Saturday, June 10th. BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Finally, Citigroup Inc. reiterated a “buy” rating and issued a $201.00 price objective (up previously from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. Two equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $193.19.

WARNING: This piece of content was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/13/sei-investments-co-has-40-72-million-position-in-thermo-fisher-scientific-inc-tmo.html.

In other news, VP Seth H. Hoogasian sold 4,140 shares of the business’s stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $177.80, for a total transaction of $736,092.00. Following the completion of the transaction, the vice president now directly owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director C Martin Harris sold 360 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total transaction of $65,149.20. Following the transaction, the director now directly owns 5,312 shares of the company’s stock, valued at $961,312.64. The disclosure for this sale can be found here. Insiders have sold 22,738 shares of company stock valued at $4,021,512 over the last three months. 0.49% of the stock is owned by corporate insiders.

Thermo Fisher Scientific Inc (TMO) opened at 194.04 on Wednesday. The company has a market capitalization of $75.70 billion, a P/E ratio of 33.80 and a beta of 1.05. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $194.30. The stock’s 50 day moving average is $178.63 and its 200-day moving average is $169.74.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The firm had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period in the previous year, the company earned $2.03 earnings per share. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. Analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. Thermo Fisher Scientific’s payout ratio is 10.45%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.